CDI
New Weapon to Prevent C. diff?
Omadacycline had demonstrated a low likelihood of causing C. difficile in clinical trials, but no one ...
JANUARY 3, 2024
FDA Approves First Orally Administered Fecal Microbiota Product to Prevent C. diff Recurrence
The FDA approved the first fecal microbiota product that is taken orally to prevent recurrent CDI in people who are ...
APRIL 27, 2023
FDA Approves Rebyota, the First Live Biotherapeutic Fecal Microbiota Product in the U.S.
RBX2660 (Rebyota, Ferring) is approved by the FDA for the prevention of recurrent Clostridioides difficile ...
DECEMBER 3, 2022
Novel Biotherapeutic Safe, Efficacious in Treating Recurrent CDI
RBX2660, a novel microbiota-based live biotherapeutic, consistently reduced rCDI among patients who are 65 years of ...
NOVEMBER 3, 2022
Limited Access to C. diff Drugs Through Medicare
While drugs recommended for the treatment of CDI are commonly included on the formularies for most people who are ...
AUGUST 23, 2022
Recently Hospitalized Patients Increase Risk for Household Transmission of CDI
Exposure to recently hospitalized family members significantly increased the risk for developing C. difficile ...
MAY 3, 2022
Rehospitalization for CDI Common; Appropriate Patient Follow-up Often Lacking
Recurrent Clostridioides difficile infection is common, yet few clinicians follow up with these patients.
SEPTEMBER 29, 2021
C. diff Testing Shouldn’t Be Based on Lab Test Alone
CDI should not be based on a laboratory test alone but should take into consideration the patient’s ...
JANUARY 30, 2019
New C. diff Rapid Diagnostic Test Registered With FDA
Matching the sensitivity and specificity of CNNA means that the new C. diff test has the potential to reduce the ...
OCTOBER 7, 2018
Chlorhexidine Bathing May Not Be More Effective Than Soap and Water to Prevent CDI
Bathing ICU patients every other day with a 2% chlorhexidine gluconate solution did not prevent hospital-acquired ...
JUNE 22, 2018
New GenePOC Test Rapidly Detects C. diff
The GenePOC CDiff assay is a qualitative, in vitro diagnostic test to detect the toxin B gene of toxigenic C. ...
NOVEMBER 30, 2017
Too Much Zinc Increases Risk for C. diff
High levels of zinc change the gut’s microbiome in a way that mimics antibiotic treatment—the primary ...
OCTOBER 6, 2016
